A cost-utility analysis of mitoxantrone hydrochloride and interferon beta-lb in the treatment of patients with secondary progressive or progressive relapsing multiple sclerosis
Daniel R. Touchette, Tracy L. Durgin, Lee A. Wanke, Donald E. GoodkinVolume:
25
Year:
2003
Language:
english
DOI:
10.1016/s0149-2918(03)80100-5
File:
PDF, 1.32 MB
english, 2003